Login / Signup

Additional analyses support superior efficacy of nirmatrelvir/ritonavir over molnupiravir for COVID-19.

Li-Chen ChangI-Wen ChenKuo-Chuan Hung
Published in: Journal of medical virology (2024)
Keyphrases
  • coronavirus disease
  • sars cov
  • antiretroviral therapy
  • respiratory syndrome coronavirus